Science Explorer Back to mapMap
Discussion
Company · Alcobendas · Spain

Eli Lilly (Spain)

In research, Eli Lilly (Spain) stands highest in Health Sciences (#8,876 of 16,688 worldwide) and Medicine (#8,943 of 14,558 worldwide), over all time.

World rank, all time
#22,721
of 34,923
Rank in Spain
#471
of 646
Research works
353
▲ 9% vs 2018-21
Citations
9.1k
25.8 per fractional work
Top-10% rate
13.0%
all institutions 10.0%
vs its own fields
0.97×
1.00× is exactly expected
Open access
37%
world 40%
International
40%
world 18%

What is Eli Lilly (Spain) known for in research?

The fields where it stands highest, over all time, ranked among every institution above the floor in each field.

FieldWorld rankWhere that sitsTop-10% rateWorks
Health SciencesDomain #8,876 of 16,688 12.7%150
MedicineField #8,943 of 14,558 11.4%138

Each strip is that field's whole ranked pool, with the notch where Eli Lilly (Spain) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no average mark, because the average differs by field (from about 6% in Dentistry to 21% in Economics).

Which fields of science does Eli Lilly (Spain) work in?

In 2022-now, 52% of research at Eli Lilly (Spain) is in Health Sciences, 21% in Physical Sciences. Its largest fields are Medicine (44%), Chemistry (10%), Biochemistry, Genetics and Molecular Biology (9%). It does 2.0× the world's share of Health Sciences.

Health Sciences: 27 fractional works · 52.2% of its workMedicine: 23 fractional works · 43.7% of its workEndocrinology, Diabetes and Metabolism: 5 fractional works · 9.9% of its workPulmonary and Respiratory Medicine: 2 fractional works · 4.6% of its workSurgery: 2 fractional works · 3.8% of its workOncology: 2 fractional works · 3.4% of its workRheumatology: 2 fractional works · 3.1% of its workDermatology: 1 fractional works · 2.5% of its workPsychiatry and Mental health: 1 fractional works · 2.5% of its workEpidemiology: 1 fractional works · 2.3% of its workPublic Health, Environmental and Occupational Health: 1 fractional works · 1.5% of its workCardiology and Cardiovascular Medicine: 1 fractional works · 1.5% of its workPhysiology: 1 fractional works · 1.3% of its workRadiology, Nuclear Medicine and Imaging: 1 fractional works · 1.2% of its workPharmacology: 1 fractional works · 1.1% of its workOrthopedics and Sports Medicine: 0 fractional works · 1.0% of its workImmunology and Allergy: 0 fractional works · 0.8% of its workGenetics: 0 fractional works · 0.7% of its workFamily Practice: 0 fractional works · 0.6% of its workNeurology: 0 fractional works · 0.5% of its workGeriatrics and Gerontology: 0 fractional works · 0.4% of its workHematology: 0 fractional works · 0.3% of its workPediatrics, Perinatology and Child Health: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.6% of its workHealth Professions: 4 fractional works · 8.4% of its workGeneral Health Professions: 3 fractional works · 5.7% of its workPharmacy: 1 fractional works · 2.7% of its workNursing: 0 fractional works · 0.1% of its workPhysical Sciences: 11 fractional works · 21.1% of its workChemistry: 5 fractional works · 10.1% of its workOrganic Chemistry: 4 fractional works · 7.0% of its workPhysical and Theoretical Chemistry: 1 fractional works · 2.1% of its workInorganic Chemistry: 0 fractional works · 0.6% of its workSpectroscopy: 0 fractional works · 0.4% of its workEngineering: 2 fractional works · 4.3% of its workBiomedical Engineering: 2 fractional works · 3.3% of its workControl and Systems Engineering: 0 fractional works · 0.9% of its workSmaller subfields together: 0 fractional works · 0.1% of its workEnvironmental Science: 2 fractional works · 3.4% of its workEnvironmental Chemistry: 1 fractional works · 2.6% of its workHealth, Toxicology and Mutagenesis: 0 fractional works · 0.6% of its workSmaller subfields together: 0 fractional works · 0.1% of its workComputer Science: 1 fractional works · 1.8% of its workInformation Systems: 1 fractional works · 1.3% of its workComputational Theory and Mathematics: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.2% of its workMaterials Science: 1 fractional works · 1.1% of its workMaterials Chemistry: 1 fractional works · 1.1% of its workEnergy: 0 fractional works · 0.3% of its workRenewable Energy, Sustainability and the Environment: 0 fractional works · 0.3% of its workEarth and Planetary Sciences: 0 fractional works · 0.0% of its workSocial Sciences: 8 fractional works · 15.3% of its workPsychology: 4 fractional works · 7.3% of its workSocial Psychology: 2 fractional works · 4.2% of its workClinical Psychology: 1 fractional works · 1.5% of its workApplied Psychology: 1 fractional works · 1.3% of its workExperimental and Cognitive Psychology: 0 fractional works · 0.3% of its workArts and Humanities: 2 fractional works · 2.9% of its workConservation: 2 fractional works · 2.9% of its workSocial Sciences: 1 fractional works · 2.8% of its workSociology and Political Science: 1 fractional works · 1.4% of its workEducation: 1 fractional works · 1.3% of its workSmaller subfields together: 0 fractional works · 0.1% of its workEconomics, Econometrics and Finance: 1 fractional works · 1.8% of its workEconomics and Econometrics: 1 fractional works · 1.5% of its workFinance: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.0% of its workBusiness, Management and Accounting: 0 fractional works · 0.5% of its workOrganizational Behavior and Human Resource Management: 0 fractional works · 0.5% of its workLife Sciences: 6 fractional works · 11.4% of its workBiochemistry, Genetics and Molecular Biology: 5 fractional works · 8.9% of its workMolecular Biology: 3 fractional works · 5.1% of its workGenetics: 1 fractional works · 1.8% of its workCell Biology: 1 fractional works · 1.1% of its workCancer Research: 0 fractional works · 0.7% of its workBiotechnology: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.1% of its workImmunology and Microbiology: 1 fractional works · 1.2% of its workImmunology: 1 fractional works · 1.2% of its workPharmacology, Toxicology and Pharmaceutics: 0 fractional works · 0.9% of its workPharmaceutical Science: 0 fractional works · 0.4% of its workPharmacology: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.1% of its workNeuroscience: 0 fractional works · 0.4% of its workNeurology: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.2% of its workALL ITS WORKEli Lilly (Spain)52fractional works, 2022-now
Life Sciences11%Physical Sciences21%Health Sciences52%Social Sciences15%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in 2022-now. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 19 fields, with their numbers
    1. Medicine2343.7%
    2. Health Professions48.4%
    3. Nursing00.1%
    1. Chemistry510.1%
    2. Engineering24.3%
    3. Environmental Science23.4%
    4. Computer Science11.8%
    5. Materials Science11.1%
    6. Energy00.3%
    7. Earth and Planetary Sciences00.0%
    1. Psychology47.3%
    2. Arts and Humanities22.9%
    3. Social Sciences12.8%
    4. Economics, Econometrics and Finance11.8%
    5. Business, Management and Accounting00.5%
    1. Biochemistry, Genetics and Molecular Biology58.9%
    2. Immunology and Microbiology11.2%
    3. Pharmacology, Toxicology and Pharmaceutics00.9%
    4. Neuroscience00.4%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 1.68× its world share, 5 worksBiochemistry, Geneti…Immunology and Microbiology: 1.17× its world share, 1 worksImmunology and Micro…Neuroscience: 0.26× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 2.46× its world share, 0 worksPharmacology, Toxico…Chemistry: 6.44× its world share, 5 worksChemistryComputer Science: 0.23× its world share, 1 worksComputer ScienceEarth and Planetary Sciences: 0.03× its world share, 0 worksEarth and Planetary …Energy: 0.35× its world share, 0 worksEnergyEngineering: 0.29× its world share, 2 worksEngineeringEnvironmental Science: 0.68× its world share, 2 worksEnvironmental ScienceMaterials Science: 0.32× its world share, 1 worksMaterials ScienceHealth Professions: 3.20× its world share, 4 worksHealth ProfessionsMedicine: 2.28× its world share, 23 worksMedicineNursing: 0.15× its world share, 0 worksNursingArts and Humanities: 1.00× its world share, 2 worksArts and HumanitiesBusiness, Management and Accounting: 0.16× its world share, 0 worksBusiness, Management…Economics, Econometrics and Finance: 0.82× its world share, 1 worksEconomics, Econometr…Psychology: 2.40× its world share, 4 worksPsychologySocial Sciences: 0.22× its world share, 2 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Chemistry, 6.4×. Every wedge is a field page.

All 19 fields, with their numbers
  1. Chemistry6.44×5 works
  2. Health Professions3.20×4 works
  3. Pharmacology, Toxicology and Pharmaceutics2.46×0 works
  4. Psychology2.40×4 works
  5. Medicine2.28×23 works
  6. Biochemistry, Genetics and Molecular Biology1.68×5 works
  7. Immunology and Microbiology1.17×1 works
  8. Arts and Humanities1.00×2 works
  9. Economics, Econometrics and Finance0.82×1 works
  10. Environmental Science0.68×2 works
  11. Energy0.35×0 works
  12. Materials Science0.32×1 works
  13. Engineering0.29×2 works
  14. Neuroscience0.26×0 works
  15. Computer Science0.23×1 works
  16. Social Sciences0.22×2 works
  17. Business, Management and Accounting0.16×0 works
  18. Nursing0.15×0 works
  19. Earth and Planetary Sciences0.03×0 works

Who are the top researchers at Eli Lilly (Spain)?

Ranked on the quality score, Marı́a José Lallena, Juan A. Rincón and Carlos Marugán lead among researchers whose main affiliation is Eli Lilly (Spain).

  1. 1 Marı́a José Lallena Spain · #207,890 worldwide 2.6k citations · 92 works
  2. 2 Juan A. Rincón Spain · #652,047 worldwide 2.2k citations · 58 works
  3. 3 Carlos Marugán Spain · #1,132,130 worldwide 647 citations · 58 works
  4. 4 Fernando Marín Spain · #1,162,948 worldwide 5.1k citations · 122 works
  5. 5 Mario Barberis Spain · #1,177,357 worldwide 1.5k citations · 26 works
  6. 6 Pablo García‐Losada Spain · #1,190,617 worldwide 1.2k citations · 25 works
  7. 7 Carlos Mateos Spain · #1,509,310 worldwide 2.2k citations · 108 works
  8. 8 Graham R. Cumming Spain · #1,682,520 worldwide 733 citations · 27 works
  9. 9 Pepa Polavieja Spain · #1,713,710 worldwide 991 citations · 39 works
  10. 10 Javier Agejas Spain · #2,045,618 worldwide 541 citations · 21 works
All ranked researchers at Eli Lilly (Spain)

What are the most cited papers from Eli Lilly (Spain)?

The most cited paper from Eli Lilly (Spain) is "The Effect of Abemaciclib Plus Fulvestrant on Overall Survival in Hormone Receptor–Positive, ERBB2-Negative Breast Cancer That Progressed on Endocrine Therapy—MONARCH 2" (George W. Sledge, Masakazu Toi, Patrick Neven et al., 2019), with 1,016 citations. Next come "Adherence to Therapies in Patients with Type 2 Diabetes" (744) and "MONARCH 3 final PFS: a randomized study of abemaciclib as initial therapy for advanced breast cancer" (693).

Most cited papers
#PaperReleasedCitations
1 The Effect of Abemaciclib Plus Fulvestrant on Overall Survival in Hormone Receptor–Positive, ERBB2-Negative Breast Cancer That Progressed on Endocrine Therapy—MONARCH 2 George W. Sledge, Masakazu Toi, Patrick Neven et al. · JAMA Oncology Open access 29 Sep 2019 1,016
2 Adherence to Therapies in Patients with Type 2 Diabetes Luis‐Emilio García‐Pérez, María Daca-Álvarez, Tatiana Dilla et al. · Diabetes Therapy Open access 29 Aug 2013 744
3 MONARCH 3 final PFS: a randomized study of abemaciclib as initial therapy for advanced breast cancer Stephen R.D. Johnston, Miguel Martín, Angelo Di Leo et al. · npj Breast Cancer Open access 11 Jan 2019 693
4 Once-weekly tirzepatide versus once-daily insulin degludec as add-on to metformin with or without SGLT2 inhibitors in patients with type 2 diabetes (SURPASS-3): a randomised, open-label, parallel-group, phase 3 trial Bernhard H. Ludvik, Francesco Giorgino, Esteban Jódar et al. · The Lancet Aug 2021 628
5 Effects of teriparatide and risedronate on new fractures in post-menopausal women with severe osteoporosis (VERO): a multicentre, double-blind, double-dummy, randomised controlled trial David L. Kendler, Fernando Marín, Cristiano A. F. Zerbini et al. · The Lancet Open access 9 Nov 2017 599
All 61 most cited papers, with filters and sorting

Which keywords describe research at Eli Lilly (Spain)?

By fractional works in 2022-now, weighted toward what it does more of than the world: Glycemic Control, Insulin Therapy, Public Health, Diabetes, Anxiety, Cardiovascular Disease, Quality of Life and Obesity.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in 2022-now in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Glycemic Control4▲ 52×4 topics
  2. Public Health4▲ 5.5×7 topics
  3. Insulin Therapy4▲ 61×3 topics
  4. Epidemiology4▲ 1.84×18 topics
  5. Quality of Life4▲ 4.7×10 topics
  6. Diabetes3▲ 13×4 topics
  7. Cardiovascular Disease3▲ 5.5×12 topics
  8. Anxiety3▲ 12×4 topics
  9. Obesity3▲ 7.0×8 topics
  10. Breast Cancer3▲ 20×3 topics
  11. Well-being3▲ 13×3 topics
  12. Type 2 Diabetes3▲ 22×3 topics
  13. Depression2▲ 5.5×5 topics
  14. Medicinal Chemistry2▲ 17×6 topics
  15. Mental Health2▲ 3.1×6 topics
  16. Neuroscience2▲ 15×3 topics
  17. Catalysis2▲ 6.0×5 topics
  18. Primary Care2▲ 11×4 topics
  19. Metastatic Breast Cancer2▲ 66×2 topics
  20. CDK4/6 Inhibitors2▲ 132×1 topic
  21. Heart Failure2▲ 8.3×5 topics
  22. Palbociclib2▲ 132×1 topic
  23. Type 1 Diabetes2▲ 42×2 topics
  24. Clinical Guidelines2▲ 11×2 topics
  25. Cancer Therapy2▲ 5.6×6 topics
  26. Cardiovascular Outcomes2▲ 54×1 topic
  27. Cardiovascular Risk2▲ 10×3 topics
  28. Complications2▲ 6.4×2 topics
  29. Glucose Control2▲ 54×1 topic
  30. Interventions2▲ 25×2 topics
  31. Lifestyle Intervention2▲ 34×2 topics
  32. Art Therapy2▲ 193×1 topic
  33. Continuous Glucose Monitoring2▲ 62×1 topic
  34. Hypoglycemia2▲ 62×1 topic
  35. Social Prescribing2▲ 193×1 topic
  36. Weight Loss1▲ 17×2 topics
  37. Positive Emotions1▲ 22×2 topics
  38. Single-Cell Analysis1▲ 46×2 topics
  39. Solvent Selection1▲ 129×1 topic
  40. Sustainable Chemistry1▲ 129×1 topic

Which research topics does Eli Lilly (Spain) publish most on?

By volume in 2022-now: Advanced Breast Cancer Therapies, Diabetes Treatment and Management, Diabetes Management and Research and Art Therapy and Mental Health.

  1. 1 Advanced Breast Cancer Therapies Pulmonary and Respiratory Medicine 2 works
  2. 2 Diabetes Treatment and Management Endocrinology, Diabetes and Metabolism 2 works
  3. 3 Diabetes Management and Research Endocrinology, Diabetes and Metabolism 2 works
  4. 4 Art Therapy and Mental Health Conservation 2 works
  5. 5 Innovative Microfluidic and Catalytic Techniques Innovation Biomedical Engineering 1 works
  6. 6 Obesity and Health Practices Pharmacy 1 works
  7. 7 Healthcare professionals’ stress and burnout General Health Professions 1 works
  8. 8 Chemistry and Chemical Engineering Environmental Chemistry 1 works
  9. 9 History and advancements in chemistry Physical and Theoretical Chemistry 1 works
  10. 10 Bariatric Surgery and Outcomes Surgery 1 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available36.6%not open63.4%

World: 40% of research is openly available.

with international co-authors39.6%domestic only60.4%

World: 18% is written across borders.

How has Eli Lilly (Spain)'s research output changed?

Output in 2022-2025 was 9% higher than in 2018-2021.

still counting1990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Eli Lilly (Spain) as a percentage of every work published that year, 0.00016% in 2024.

still counting0.00050%0.0010%0.0015%Eli Lilly (Spain)0.00013% in 202519801990200020102020

Fractional works of Eli Lilly (Spain) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Alcobendas

All research institutions in Alcobendas

Share Eli Lilly (Spain)'s ranking

Eli Lilly (Spain) on Science Explorer

A card with Eli Lilly (Spain)'s standing and the fields it leads in, for a post or a slide. A link to this page previews as the same card.

Download the card

1200 × 630 PNG, sized for social posts, drawn from the latest snapshot.

Badges for a website1Each links back here and updates with every snapshot

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Eli Lilly (Spain). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.